| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Bazemore Todd | SEE REMARKS | Jan 04, 2024 | Sale | $6.74 | 1,405 | 9,470 | 89,786 | Jan 05, 2024, 04:03 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | SEE REMARKS | Jan 04, 2023 | Sale | $28.54 | 62 | 1,769 | 14,835 | Jan 06, 2023, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | SEE REMARKS | Oct 26, 2022 | Sale | $6.51 | 214 | 1,393 | 2,097 | Oct 28, 2022, 04:15 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | SEE REMARKS | Jun 27, 2022 | Sale | $0.37 | 3,092 | 1,144 | 115,499 | Jun 29, 2022, 08:10 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | SEE REMARKS | Jan 04, 2022 | Sale | $1.30 | 3,454 | 4,490 | 118,591 | Jan 05, 2022, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | CHIEF OPERATING OFFICER | Oct 26, 2021 | Sale | $1.80 | 12,544 | 22,579 | 122,045 | Oct 28, 2021, 08:03 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | CHIEF OPERATING OFFICER | Jun 28, 2021 | Sale | $5.77 | 2,911 | 16,796 | 134,589 | Jun 29, 2021, 05:25 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | Chief Operating Officer | Jun 05, 2020 | Buy | $13.39 | 2 | 27 | 2 | Oct 28, 2020, 08:36 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | Chief Operating Officer | Oct 22, 2020 | Buy | $7.60 | 40 | 304 | 42 | Oct 28, 2020, 08:36 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Bazemore Todd | Chief Operating Officer | Mar 16, 2020 | Buy | $5.75 | 10,000 | 57,500 | 10,000 | Mar 17, 2020, 05:46 PM | |
| DYAX | DYAX CORP | Bazemore Todd | EVP & Chief Commercial Officer | Aug 18, 2015 | Option Exercise | $6.80 | 13,750 | 93,500 | 13,750 | Aug 19, 2015, 04:18 PM | |
| DYAX | DYAX CORP | Bazemore Todd | EVP & Chief Commercial Officer | Aug 04, 2015 | Option Exercise | $15.22 | 66,000 | 1,004,718 | 33,000 | Aug 06, 2015, 04:35 PM | |
| DYAX | DYAX CORP | Bazemore Todd | EVP & Chief Commercial Officer | Aug 05, 2015 | Option Exercise | $15.17 | 20,000 | 303,305 | 10,000 | Aug 06, 2015, 04:35 PM |
Menu